264 related articles for article (PubMed ID: 11362747)
1. Clarithromycin prophylaxis against disseminated Mycobacterium avium complex in patients with AIDS.
Archange YR; Carrey Z; Zanlungo PG
J Int Assoc Physicians AIDS Care; 1995 Aug; 1(7):20-2. PubMed ID: 11362747
[TBL] [Abstract][Full Text] [Related]
2. A randomized trial of clarithromycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome.
Pierce M; Crampton S; Henry D; Heifets L; LaMarca A; Montecalvo M; Wormser GP; Jablonowski H; Jemsek J; Cynamon M; Yangco BG; Notario G; Craft JC
N Engl J Med; 1996 Aug; 335(6):384-91. PubMed ID: 8663871
[TBL] [Abstract][Full Text] [Related]
3. Abbott files SNDA for MAC prophylaxis.
J Int Assoc Physicians AIDS Care; 1995 Jun; 1(5):32. PubMed ID: 11362606
[TBL] [Abstract][Full Text] [Related]
4. The role of clarithromycin in the prophylaxis of disseminated Mycobacterium avium-intracellulare infection in patients with AIDS.
Mertl SL
Pharmacotherapy; 1996; 16(3):393-400. PubMed ID: 8726597
[TBL] [Abstract][Full Text] [Related]
5. Prevention strategies for Mycobacterium avium-intracellulare complex (MAC) infection. A review of recent studies in patients with AIDS.
Cohn DL
Drugs; 1997; 54 Suppl 2():8-15; discussion 28-9. PubMed ID: 9358195
[TBL] [Abstract][Full Text] [Related]
6. Antivirals key to MAC prevention regimen.
AIDS Alert; 1996 Sep; 11(9):101-3. PubMed ID: 11363722
[TBL] [Abstract][Full Text] [Related]
7. Presence of macrolide resistance in respiratory flora of HIV-Infected patients receiving either clarithromycin or azithromycin for Mycobacterium avium complex prophylaxis.
Aberg JA; Wong MK; Flamm R; Notario GF; Jacobson MA
HIV Clin Trials; 2001; 2(6):453-9. PubMed ID: 11742432
[TBL] [Abstract][Full Text] [Related]
8. Prophylaxis against disseminated Mycobacterium avium complex in AIDS.
Ong EL
J Infect; 1999 Jan; 38(1):6-8. PubMed ID: 10090497
[No Abstract] [Full Text] [Related]
9. MAC prophylaxis revisited.
Torres G
GMHC Treat Issues; 1996 Apr; 10(4):6-7, 10. PubMed ID: 11363706
[TBL] [Abstract][Full Text] [Related]
10. Prevention of disseminated Mycobacterium avium complex infection with reduced dose clarithromycin in patients with advanced HIV disease.
Hewitt RG; Papandonatos GD; Shelton MJ; Hsiao CB; Harmon BJ; Kaczmarek SR; Amsterdam D
AIDS; 1999 Jul; 13(11):1367-72. PubMed ID: 10449290
[TBL] [Abstract][Full Text] [Related]
11. Clarithromycin prophylaxis against Cryptosporidium enteritis in patients with AIDS.
Jordan WC
J Natl Med Assoc; 1996 Jul; 88(7):425-7. PubMed ID: 8764523
[TBL] [Abstract][Full Text] [Related]
12. Clarithromycin or rifabutin alone or in combination for primary prophylaxis of Mycobacterium avium complex disease in patients with AIDS: A randomized, double-blind, placebo-controlled trial. The AIDS Clinical Trials Group 196/Terry Beirn Community Programs for Clinical Research on AIDS 009 Protocol Team.
Benson CA; Williams PL; Cohn DL; Becker S; Hojczyk P; Nevin T; Korvick JA; Heifets L; Child CC; Lederman MM; Reichman RC; Powderly WG; Notario GF; Wynne BA; Hafner R
J Infect Dis; 2000 Apr; 181(4):1289-97. PubMed ID: 10762562
[TBL] [Abstract][Full Text] [Related]
13. Mononuclear and polymorphonuclear leukocyte dispositions of clarithromycin and azithromycin in AIDS patients requiring Mycobacterium avium complex prophylaxis.
Bui KQ; McNabb J; Li C; Nightingale CH; Nicolau DP
Antimicrob Agents Chemother; 1999 Sep; 43(9):2302-4. PubMed ID: 10471584
[TBL] [Abstract][Full Text] [Related]
14. Clarithromycin. A review of its pharmacological properties and therapeutic use in Mycobacterium avium-intracellulare complex infection in patients with acquired immune deficiency syndrome.
Barradell LB; Plosker GL; McTavish D
Drugs; 1993 Aug; 46(2):289-312. PubMed ID: 7691518
[TBL] [Abstract][Full Text] [Related]
15. Controversies in the management of Mycobacterium avium complex infection in AIDS patients.
Peloquin CA
Ann Pharmacother; 1993; 27(7-8):928-37. PubMed ID: 8364280
[TBL] [Abstract][Full Text] [Related]
16. Clarithromycin resistance and susceptibility patterns of Mycobacterium avium strains isolated during prophylaxis for disseminated infection in patients with AIDS.
Craft JC; Notario GF; Grosset JH; Heifets LB
Clin Infect Dis; 1998 Oct; 27(4):807-12. PubMed ID: 9798037
[TBL] [Abstract][Full Text] [Related]
17. Activity of clarithromycin against Mycobacterium avium infection in patients with the acquired immune deficiency syndrome. A controlled clinical trial.
Dautzenberg B; Truffot C; Legris S; Meyohas MC; Berlie HC; Mercat A; Chevret S; Grosset J
Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):564-9. PubMed ID: 1832527
[TBL] [Abstract][Full Text] [Related]
18. Rationale for the prevention of disseminated Mycobacterium avium-intracellulare complex disease.
Dautzenberg B
Drugs; 1997; 54 Suppl 2():1-7; discussion 28-9. PubMed ID: 9358194
[TBL] [Abstract][Full Text] [Related]
19. Acquired resistance in Mycobacterium avium complex strains isolated from AIDS patients and beige mice during treatment with clarithromycin.
Doucet-Populaire F; Truffot-Pernot C; Grosset J; Jarlier V
J Antimicrob Chemother; 1995 Jul; 36(1):129-36. PubMed ID: 8537260
[TBL] [Abstract][Full Text] [Related]
20. Current strategies for the prevention and treatment of disseminated Mycobacterium avium complex infection in patients with AIDS.
Wright J
Pharmacotherapy; 1998; 18(4):738-47. PubMed ID: 9692648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
